EudraGMP Homepage      
 
 
MIA | GMP | API REG | WDA | GDP | Sites Help
Tue 17 Nov 2026 16:21:09 BST
GMP Compliance Menu 
Search
GMP Certificates
Non-Compliance Report


Print Preview
                  
Print Preview (Short version)
                  
Back To Search

 

Agency For Medicinal Products And Medical Devices Of The Republic Of Slovenia

CERTIFICATE NUMBER: 401-24/2025-5

CERTIFICATE OF GMP COMPLIANCE OF A MANUFACTURER(1) , (2)

Part 1

Issued following an inspection in accordance with
Art. 111(5) of Directive 2001/83/EC as amended
Art. 63 of Regulation (EU) 536/2014 as amended

The competent authority of Slovenia confirms the following:

The manufacturer: Lek Pharmaceuticals d.d.

Site address: Verovskova Ulica 57, Ljubljana, 1526, Slovenia

OMS Organisation Id. / OMS Location Id.: ORG-100000695 / LOC-100002319

 DUNS Number: 36-470-4288

Has been inspected under the national inspection programme in connection with manufacturing authorisation no.  800-6/2024-14  in accordance with Art. 61 of Regulation (EU) No 536/2014 and Art. 40 of Directive 2001/83/EC.


From the knowledge gained during inspection of this manufacturer, the latest of which was conducted on  2025-11-18 , it is considered that it complies with:

  • The principles and guidelines of Good Manufacturing Practice laid down in Directive (EU) 2017/1572 and/or Commission Delegated Regulation (EU) 2017/1569, as reflected by the product categories stated in Part 2. (3)

  • This certificate reflects the status of the manufacturing site at the time of the inspection noted above and should not be relied upon to reflect the compliance status if more than three years have elapsed since the date of that inspection. However, this period of validity may be reduced or extended using regulatory risk management principles by an entry in the Restrictions or Clarifying remarks field. Updates to restrictions or clarifying remarks can be identified through the EudraGMDP website (https://eudragmdp.ema.europa.eu/). This certificate is valid only when presented with all pages and both Parts 1 and 2.

     The authenticity of this certificate may be verified in EudraGMDP. If it does not appear, please contact the issuing authority.

    __________________________________________________________________________________________________________________________
    (1) The certificate referred to in paragraph Art. 111(5) of Directive 2001/83/EC and Art. 15 of Directive 2001/20/ECis also applicable to importers.
    (2) Guidance on the interpretation of this template can be found in the Interpretation of the Union format for GMP certificate.
    (3) These requirements fulfil the GMP recommendations of WHO.

    Part 2

    Human Medicinal Products
    Human Investigational Medicinal Products

    1  MANUFACTURING OPERATIONS
    1.1  Sterile products
       1.1.1  Aseptically prepared (processing operations for the following dosage forms)
               1.1.1.2  Lyophilisates
                      Special Requirements:
                       7  Other: Prostaglandines, Cytokines, Cytotoxics/Cytostatics, Immunosuppresives(en)
               1.1.1.4  Small volume liquids
                      Special Requirements:
                       7  Other: Hormones or Substance with Hormonal Activity, Cytotoxics/Cytostatics(en)
       1.1.2  Terminally Sterilised (processing operations for the following dosage forms)
               1.1.2.3  Small volume liquids
                      Special Requirements:
                       7  Other: Hormones or Substance with Hormonal Activity(en)
       1.1.3  Batch certification
    1.2  Non-sterile products
       1.2.1  Non-sterile products (processing operations for the following dosage forms)
               1.2.1.1  Capsules, hard shell
                      Special Requirements:
                       7  Other: Cytotoxics/Cytostatics, Immunosuppresives(en)
               1.2.1.5  Liquids for external use
                      Special Requirements:
                       7  Other: Hormones or Substance with Hormonal Activity(en)
               1.2.1.6  Liquids for internal use
                      Special Requirements:
                       7  Other: Hormones or Substance with Hormonal Activity(en)
               1.2.1.8  Other solid dosage forms: granules, pellets, micropellets, granulates, powders, mini tablets(en)
               1.2.1.13  Tablets
                      Special Requirements:
                       7  Other: Hormones or Sustance with Hormonal Activity, Cytotoxics/Cytostatics, Immunosuppresives(en)
       1.2.2  Batch certification
    1.3  Biological medicinal products (list of product types)
       1.3.1  Biological medicinal products (list of product types)
               1.3.1.2  Immunological products
               1.3.1.5  Biotechnology products
       1.3.2  Batch Certification (list of product types)
               1.3.2.2  Immunological products
               1.3.2.5  Biotechnology products
    1.5  Packaging
       1.5.1  Primary Packaging
               1.5.1.1  Capsules, hard shell
                      Special Requirements:
                       7  Other: Cytotoxics/Cytostatics, Immunosuppresives(en)
               1.5.1.5  Liquids for external use
                      Special Requirements:
                       7  Other: Hormones or Substance with Hormonal Activity(en)
               1.5.1.6  Liquids for internal use
                      Special Requirements:
                       7  Other: Hormones or Substance with Hormonal Activity(en)
               1.5.1.8  Other solid dosage forms: granules, pellets, micropellets, granulates, powders, mini tablets(en)
               1.5.1.13  Tablets
                      Special Requirements:
                       7  Other: Hormones or Substance with Hormonal Activity, Cytotoxics/Cytostatics, Immunosuppresives(en)
       1.5.2  Secondary packaging
    1.6  Quality control testing
       1.6.1  Microbiological: sterility
       1.6.2  Microbiological: non-sterility
       1.6.3  Chemical/Physical
       1.6.4  Biological

    2  IMPORTATION OF MEDICINAL PRODUCTS
    2.1  Quality control testing of imported medicinal products
       2.1.1  Microbiological: sterility
       2.1.2  Microbiological: non-sterility
       2.1.3  Chemical/Physical
       2.1.4  Biological
    2.2  Batch certification of imported medicinal products
       2.2.1  Sterile products
               2.2.1.1  Aseptically prepared
               2.2.1.2  Terminally sterilised
       2.2.2  Non-sterile products
       2.2.3  Biological medicinal products
               2.2.3.2  Immunological products
               2.2.3.5  Biotechnology products
               2.2.3.8  Other: Lyophilised Bacterial Lysate(en)
    2.3  Other importation activities
       2.3.1  Site of physical importation
       2.3.2  Importation of intermediate which undergoes further processing
       2.3.3  Biological active substance
       2.3.4  Other: Herbal Products(en)

    Clarifying remarks (for public users):
    Manufacturing activities 1.2.1.1, 1.2.1.8, 1.2.1.13, 1.5.1.1, 1.5.1.8, 1.5.1.13 are only performed for Investigational medicinal products. Import activity 2.2.3.2 only performed for Investigational medicinal product. Import activity 2.2.3.8 only performed for Human medicinal products. 2.3.1 Site of physical importation: The actual location of reception and storage of imported products is the contractual partner: KUEHNE + NAGEL d. o. o., Zgornji Brnik 300, 4210 Brnik - Aerodrom. 2.3.2 Importation of intermediate which undergoes further processing include: Aseptically prepared products (Lyophilisates, Small volume liquids), Terminally sterilised (Small volume liquides), non-sterile products (Capsules, hard and soft shell, Tablets, granulate). Manufacturing site address in Slovenian language: Lek farmacevtska družba d.d., Verovškova ulica 57, 1526 Ljubljana, Slovenija

     

     



     
     
     
         
     
     
     
     
    The EudraGMDP database is maintained and operated by the EMA. Access to the general public is granted in order to enhance availability of information related to the EMA mandate. The content of the database is provided by the National Competent Authorities (NCA) of the EEA. For this reason, the EMA accepts no responsibility or liability whatsoever (including but not limited to any direct or consequential loss or damage it might occur to you and/or any other third party) arising out of or in connection with the information on this database. Any questions about the content should be addressed to the relevant NCA. Please click here to get list of NCA's.

    For the UK, as from 1.1.2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI.

    Documents issued by UK authorities up to and including 31 December 2020 remain available for consultation in EudraGMDP. However, they are no longer included or updated from 1 January 2021, with the exception of the documents pertaining to sites located in Northern Ireland.

    [EMA © 2014. EudraGMDP 6.5.4.8 build 2026/01/16 09:45]